[
  {
    "title": "Why AstraZeneca Wants To Buy Alexion Pharmaceuticals - Forbes",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Why AstraZeneca Wants To Buy Alexion Pharmaceuticals - Forbes"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.forbes.com/sites/greatspeculations/2020/12/14/why-astrazeneca-wants-to-buy-alexion-pharmaceuticals/"
      }
    ],
    "link": "https://www.forbes.com/sites/greatspeculations/2020/12/14/why-astrazeneca-wants-to-buy-alexion-pharmaceuticals/",
    "id": "52781240492837",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:13:27 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      13,
      27,
      0,
      349,
      0
    ],
    "summary": "<ol><li><a href=\"https://www.forbes.com/sites/greatspeculations/2020/12/14/why-astrazeneca-wants-to-buy-alexion-pharmaceuticals/\" target=\"_blank\">Why AstraZeneca Wants To Buy Alexion Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Forbes</font></li><li><a href=\"https://www.fool.com/investing/2020/12/14/why-alexion-pharmaceuticals-is-soaring-today/\" target=\"_blank\">Why Alexion Pharmaceuticals Is Soaring and AstraZeneca Is Sinking Today</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Motley Fool</font></li><li><a href=\"https://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-alexion/\" target=\"_blank\">AstraZeneca to acquire biopharmaceutical firm Alexion for $39bn</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">pharmaceutical-technology.com</font></li><li><a href=\"https://www.wbap.com/news/astrazeneca-shares-fall-on-hefty-39b-alexion-deal/\" target=\"_blank\">AstraZeneca Shares Fall on 'Hefty' $39B Alexion Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">WBAP News/Talk</font></li><li><a href=\"https://247wallst.com/healthcare-business/2020/12/14/what-this-alexion-acquisition-means-for-astrazeneca/\" target=\"_blank\">What This Alexion Acquisition Means for AstraZeneca</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">24/7 Wall St.</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlseHR5NGtZQU1FV3pBc1VsWmFkTHJLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<ol><li><a href=\"https://www.forbes.com/sites/greatspeculations/2020/12/14/why-astrazeneca-wants-to-buy-alexion-pharmaceuticals/\" target=\"_blank\">Why AstraZeneca Wants To Buy Alexion Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Forbes</font></li><li><a href=\"https://www.fool.com/investing/2020/12/14/why-alexion-pharmaceuticals-is-soaring-today/\" target=\"_blank\">Why Alexion Pharmaceuticals Is Soaring and AstraZeneca Is Sinking Today</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Motley Fool</font></li><li><a href=\"https://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-alexion/\" target=\"_blank\">AstraZeneca to acquire biopharmaceutical firm Alexion for $39bn</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">pharmaceutical-technology.com</font></li><li><a href=\"https://www.wbap.com/news/astrazeneca-shares-fall-on-hefty-39b-alexion-deal/\" target=\"_blank\">AstraZeneca Shares Fall on 'Hefty' $39B Alexion Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">WBAP News/Talk</font></li><li><a href=\"https://247wallst.com/healthcare-business/2020/12/14/what-this-alexion-acquisition-means-for-astrazeneca/\" target=\"_blank\">What This Alexion Acquisition Means for AstraZeneca</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">24/7 Wall St.</font></li><li><strong><a href=\"https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlseHR5NGtZQU1FV3pBc1VsWmFkTHJLQUFQAQ?oc=5\" target=\"_blank\">View Full Coverage on Google News</a></strong></li></ol>"
    },
    "source": {
      "href": "https://www.forbes.com",
      "title": "Forbes"
    },
    "sub_articles": [
      {
        "url": "https://www.forbes.com/sites/greatspeculations/2020/12/14/why-astrazeneca-wants-to-buy-alexion-pharmaceuticals/",
        "title": "Why AstraZeneca Wants To Buy Alexion Pharmaceuticals",
        "publisher": "Forbes"
      },
      {
        "url": "https://www.fool.com/investing/2020/12/14/why-alexion-pharmaceuticals-is-soaring-today/",
        "title": "Why Alexion Pharmaceuticals Is Soaring and AstraZeneca Is Sinking Today",
        "publisher": "Motley Fool"
      },
      {
        "url": "https://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-alexion/",
        "title": "AstraZeneca to acquire biopharmaceutical firm Alexion for $39bn",
        "publisher": "pharmaceutical-technology.com"
      },
      {
        "url": "https://www.wbap.com/news/astrazeneca-shares-fall-on-hefty-39b-alexion-deal/",
        "title": "AstraZeneca Shares Fall on 'Hefty' $39B Alexion Deal",
        "publisher": "WBAP News/Talk"
      },
      {
        "url": "https://247wallst.com/healthcare-business/2020/12/14/what-this-alexion-acquisition-means-for-astrazeneca/",
        "title": "What This Alexion Acquisition Means for AstraZeneca",
        "publisher": "24/7 Wall St."
      }
    ]
  },
  {
    "title": "AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover - Report Door",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover - Report Door"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/"
      }
    ],
    "link": "https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/",
    "id": "CBMiZGh0dHBzOi8vd3d3LnJlcG9ydGRvb3IuY29tL2FzdHJhemVuZWNhLXN0b2NrLXR1bWJsZXMtb24tMzktYmlsbGlvbi1hbGV4aW9uLXBoYXJtYWNldXRpY2Fscy10YWtlb3Zlci_SAQA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:45:46 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      45,
      46,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/\" target=\"_blank\">AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Report Door</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.reportdoor.com/astrazeneca-stock-tumbles-on-39-billion-alexion-pharmaceuticals-takeover/\" target=\"_blank\">AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Report Door</font>"
    },
    "source": {
      "href": "https://www.reportdoor.com",
      "title": "Report Door"
    },
    "sub_articles": []
  },
  {
    "title": "Boutique Firms Steal the Show on Year\u2019s Top Health-Care Deal - Bloomberg",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Boutique Firms Steal the Show on Year\u2019s Top Health-Care Deal - Bloomberg"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.bloomberg.com/news/articles/2020-12-14/boutique-firms-steal-the-show-on-year-s-top-health-care-deal"
      }
    ],
    "link": "https://www.bloomberg.com/news/articles/2020-12-14/boutique-firms-steal-the-show-on-year-s-top-health-care-deal",
    "id": "CBMib2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIwLTEyLTE0L2JvdXRpcXVlLWZpcm1zLXN0ZWFsLXRoZS1zaG93LW9uLXllYXItcy10b3AtaGVhbHRoLWNhcmUtZGVhbNIBc2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vYW1wL25ld3MvYXJ0aWNsZXMvMjAyMC0xMi0xNC9ib3V0aXF1ZS1maXJtcy1zdGVhbC10aGUtc2hvdy1vbi15ZWFyLXMtdG9wLWhlYWx0aC1jYXJlLWRlYWw",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:23:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      23,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.bloomberg.com/news/articles/2020-12-14/boutique-firms-steal-the-show-on-year-s-top-health-care-deal\" target=\"_blank\">Boutique Firms Steal the Show on Year\u2019s Top Health-Care Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.bloomberg.com/news/articles/2020-12-14/boutique-firms-steal-the-show-on-year-s-top-health-care-deal\" target=\"_blank\">Boutique Firms Steal the Show on Year\u2019s Top Health-Care Deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg</font>"
    },
    "source": {
      "href": "https://www.bloomberg.com",
      "title": "Bloomberg"
    },
    "sub_articles": []
  },
  {
    "title": "Biotechs Rally to Record on Vaccine Distribution, Deal Optimism - Bloomberg",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Biotechs Rally to Record on Vaccine Distribution, Deal Optimism - Bloomberg"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.bloomberg.com/news/articles/2020-12-14/biotechs-rally-to-record-on-vaccine-distribution-deal-optimism"
      }
    ],
    "link": "https://www.bloomberg.com/news/articles/2020-12-14/biotechs-rally-to-record-on-vaccine-distribution-deal-optimism",
    "id": "CAIiELJ9dUmUlpqH-pZfIwQhsqgqGQgEKhAIACoHCAow4uzwCjCF3bsCMIrOrwM",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:21:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      21,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://www.bloomberg.com/news/articles/2020-12-14/biotechs-rally-to-record-on-vaccine-distribution-deal-optimism\" target=\"_blank\">Biotechs Rally to Record on Vaccine Distribution, Deal Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.bloomberg.com/news/articles/2020-12-14/biotechs-rally-to-record-on-vaccine-distribution-deal-optimism\" target=\"_blank\">Biotechs Rally to Record on Vaccine Distribution, Deal Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg</font>"
    },
    "source": {
      "href": "https://www.bloomberg.com",
      "title": "Bloomberg"
    },
    "sub_articles": []
  },
  {
    "title": "U.S. Stocks Rise on Vaccine Rollout; Oil Slumps: Markets Wrap - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "U.S. Stocks Rise on Vaccine Rollout; Oil Slumps: Markets Wrap - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/pound-rises-early-trade-brexit-201755376.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/pound-rises-early-trade-brexit-201755376.html",
    "id": "CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wb3VuZC1yaXNlcy1lYXJseS10cmFkZS1icmV4aXQtMjAxNzU1Mzc2Lmh0bWzSAVRodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9wb3VuZC1yaXNlcy1lYXJseS10cmFkZS1icmV4aXQtMjAxNzU1Mzc2Lmh0bWw",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:35:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      35,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/pound-rises-early-trade-brexit-201755376.html\" target=\"_blank\">U.S. Stocks Rise on Vaccine Rollout; Oil Slumps: Markets Wrap</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/pound-rises-early-trade-brexit-201755376.html\" target=\"_blank\">U.S. Stocks Rise on Vaccine Rollout; Oil Slumps: Markets Wrap</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Going to China? ADC Therapeutics spotlights a new way to do it with Hillhouse-backed Overland - Endpoints News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Going to China? ADC Therapeutics spotlights a new way to do it with Hillhouse-backed Overland - Endpoints News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://endpts.com/going-to-china-adc-therapeutics-spotlights-a-new-way-to-do-it-with-hillhouse-backed-overland/"
      }
    ],
    "link": "https://endpts.com/going-to-china-adc-therapeutics-spotlights-a-new-way-to-do-it-with-hillhouse-backed-overland/",
    "id": "CBMicGh0dHBzOi8vZW5kcHRzLmNvbS9nb2luZy10by1jaGluYS1hZGMtdGhlcmFwZXV0aWNzLXNwb3RsaWdodHMtYS1uZXctd2F5LXRvLWRvLWl0LXdpdGgtaGlsbGhvdXNlLWJhY2tlZC1vdmVybGFuZC_SAQA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:11:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      11,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://endpts.com/going-to-china-adc-therapeutics-spotlights-a-new-way-to-do-it-with-hillhouse-backed-overland/\" target=\"_blank\">Going to China? ADC Therapeutics spotlights a new way to do it with Hillhouse-backed Overland</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://endpts.com/going-to-china-adc-therapeutics-spotlights-a-new-way-to-do-it-with-hillhouse-backed-overland/\" target=\"_blank\">Going to China? ADC Therapeutics spotlights a new way to do it with Hillhouse-backed Overland</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>"
    },
    "source": {
      "href": "https://endpts.com",
      "title": "Endpoints News"
    },
    "sub_articles": []
  },
  {
    "title": "News briefing: Arvinas shares double on interim data for two cancer programs; UK biopharma snaps up oncology CRO - Endpoints News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "News briefing: Arvinas shares double on interim data for two cancer programs; UK biopharma snaps up oncology CRO - Endpoints News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://endpts.com/news-briefing-arvinas-shares-double-on-interim-data-for-two-cancer-programs-uk-biopharma-snaps-up-oncology-cro/"
      }
    ],
    "link": "https://endpts.com/news-briefing-arvinas-shares-double-on-interim-data-for-two-cancer-programs-uk-biopharma-snaps-up-oncology-cro/",
    "id": "CBMiggFodHRwczovL2VuZHB0cy5jb20vbmV3cy1icmllZmluZy1hcnZpbmFzLXNoYXJlcy1kb3VibGUtb24taW50ZXJpbS1kYXRhLWZvci10d28tY2FuY2VyLXByb2dyYW1zLXVrLWJpb3BoYXJtYS1zbmFwcy11cC1vbmNvbG9neS1jcm8v0gEA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:04:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      4,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://endpts.com/news-briefing-arvinas-shares-double-on-interim-data-for-two-cancer-programs-uk-biopharma-snaps-up-oncology-cro/\" target=\"_blank\">News briefing: Arvinas shares double on interim data for two cancer programs; UK biopharma snaps up oncology CRO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://endpts.com/news-briefing-arvinas-shares-double-on-interim-data-for-two-cancer-programs-uk-biopharma-snaps-up-oncology-cro/\" target=\"_blank\">News briefing: Arvinas shares double on interim data for two cancer programs; UK biopharma snaps up oncology CRO</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>"
    },
    "source": {
      "href": "https://endpts.com",
      "title": "Endpoints News"
    },
    "sub_articles": []
  },
  {
    "title": "SolarWinds says that 'fewer than 18,000 customers' had software compromised in hack - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "SolarWinds says that 'fewer than 18,000 customers' had software compromised in hack - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/solarwinds-says-fewer-18-000-154937914.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/solarwinds-says-fewer-18-000-154937914.html",
    "id": "CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zb2xhcndpbmRzLXNheXMtZmV3ZXItMTgtMDAwLTE1NDkzNzkxNC5odG1s0gFSaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3Mvc29sYXJ3aW5kcy1zYXlzLWZld2VyLTE4LTAwMC0xNTQ5Mzc5MTQuaHRtbA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 15:49:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      15,
      49,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/solarwinds-says-fewer-18-000-154937914.html\" target=\"_blank\">SolarWinds says that 'fewer than 18,000 customers' had software compromised in hack</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/solarwinds-says-fewer-18-000-154937914.html\" target=\"_blank\">SolarWinds says that 'fewer than 18,000 customers' had software compromised in hack</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Charles Schwab users face trade execution troubles - Downdetector - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Charles Schwab users face trade execution troubles - Downdetector - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/charles-schwab-users-face-trade-155325447.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/charles-schwab-users-face-trade-155325447.html",
    "id": "CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jaGFybGVzLXNjaHdhYi11c2Vycy1mYWNlLXRyYWRlLTE1NTMyNTQ0Ny5odG1s0gFVaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvY2hhcmxlcy1zY2h3YWItdXNlcnMtZmFjZS10cmFkZS0xNTUzMjU0NDcuaHRtbA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 15:53:00 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      15,
      53,
      0,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/charles-schwab-users-face-trade-155325447.html\" target=\"_blank\">Charles Schwab users face trade execution troubles - Downdetector</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/charles-schwab-users-face-trade-155325447.html\" target=\"_blank\">Charles Schwab users face trade execution troubles - Downdetector</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Is Alexion Pharmaceuticals Inc. (ALXN) a Keeper? - The News Heater",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Is Alexion Pharmaceuticals Inc. (ALXN) a Keeper? - The News Heater"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://newsheater.com/2020/12/14/is-alexion-pharmaceuticals-inc-alxn-a-keeper/"
      }
    ],
    "link": "https://newsheater.com/2020/12/14/is-alexion-pharmaceuticals-inc-alxn-a-keeper/",
    "id": "CBMiT2h0dHBzOi8vbmV3c2hlYXRlci5jb20vMjAyMC8xMi8xNC9pcy1hbGV4aW9uLXBoYXJtYWNldXRpY2Fscy1pbmMtYWx4bi1hLWtlZXBlci_SAVNodHRwczovL25ld3NoZWF0ZXIuY29tLzIwMjAvMTIvMTQvaXMtYWxleGlvbi1waGFybWFjZXV0aWNhbHMtaW5jLWFseG4tYS1rZWVwZXIvP2FtcA",
    "guidislink": false,
    "published": "Mon, 14 Dec 2020 16:09:28 GMT",
    "published_parsed": [
      2020,
      12,
      14,
      16,
      9,
      28,
      0,
      349,
      0
    ],
    "summary": "<a href=\"https://newsheater.com/2020/12/14/is-alexion-pharmaceuticals-inc-alxn-a-keeper/\" target=\"_blank\">Is Alexion Pharmaceuticals Inc. (ALXN) a Keeper?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The News Heater</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://newsheater.com/2020/12/14/is-alexion-pharmaceuticals-inc-alxn-a-keeper/\" target=\"_blank\">Is Alexion Pharmaceuticals Inc. (ALXN) a Keeper?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The News Heater</font>"
    },
    "source": {
      "href": "https://newsheater.com",
      "title": "The News Heater"
    },
    "sub_articles": []
  }
]